# Eli Lilly and Company (LLY) — Q1-2019 Earnings Results

**Report date:** 2019-04-30 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q1-2019

## Post-Earnings Brief

### Headline

Eli Lilly Misses on EPS — Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.33 | N/A | -2.12% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed confidence in their pipeline and future growth. However, they acknowledged the challenges faced in the current quarter.

**Key quotes:**

> We are focused on delivering innovative solutions for patients.

> Our pipeline remains strong, and we are committed to our long-term goals.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Eli Lilly's earnings report indicates a slight miss on EPS expectations, which may raise concerns among investors. The lack of revenue data and guidance could lead to uncertainty in the stock's performance. Management's focus on innovation and a strong pipeline suggests a long-term positive outlook, but immediate reactions may be muted due to the EPS miss.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q1-2019_